Between August and September 2024, 486 new people joined the group lawsuit for people harmed by Rybelsus and other GLP-1 drugs
In UK clinical practice, healthcare professionals should be aware that while metallic taste is not a commonly documented side effect, individual patients may experience it
If pain persists despite appropriate analgesia, underlying causes should be investigated rather than simply increasing medication doses
Platform for pharmaceutical development and commercialization Ro's de-identified patient data and direct-to-patient platform are becoming infrastructure for pharmaceutical development and commercialization
As real-world evidence is very limited, we explored the association between GLP-1RA and suicide/self-injury by mining the FDA Adverse Event Reporting System (FAERS) database
In an open trial, taking a fermented milk supplement containing a combination of B